POST-PV MF
Clinical trials for POST-PV MF explained in plain language.
Never miss a new study
Get alerted when new POST-PV MF trials appear
Sign up with your email to follow new studies for POST-PV MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink spleens and ease symptoms in myelofibrosis patients
Disease control Recruiting nowThis study tests whether adding navtemadlin to the standard drug ruxolitinib helps people with myelofibrosis who are not getting enough benefit from ruxolitinib alone. About 600 adults with myelofibrosis will first take ruxolitinib, then those with a weak response will be randoml…
Matched conditions: POST-PV MF
Phase: PHASE3 • Sponsor: Kartos Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term registry for people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, surveys, and insurance data from 5,000 participants over at least five years to understand how the disease progresses an…
Matched conditions: POST-PV MF
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 12:09 UTC